SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-060553
Filing Date
2024-05-15
Accepted
2024-05-15 16:45:13
Documents
13
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20240515.htm   iXBRL 8-K 39413
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 153938
3 GRAPHIC img90053791_0.jpg GRAPHIC 46853
  Complete submission text file 0000950170-24-060553.txt   388742

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240515.xsd EX-101.SCH 25993
16 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240515_htm.xml XML 4928
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 24952055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)